Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Impact of Thrombotic Events Occurring during Active Treatment of Leukemia on the Overall Survival and Event-Free Survival: A Systematic Review

Surabhi Sivaratnam, Uma H. Athale

Blood (2022) 140 (Supplement 1): 6049–6050.

https://doi.org/10.1182/blood-2022-170502

Published: 2022

Journal Articles

Universal Premedication for Pegylated (PEG)-Asparaginase Treatment in Children with Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LLy) Has No Impact on Frequency of Hypersensitivity Reactions

Andres Felipe Fajardo, Stephanie Cox, Paula MacDonald, Sabrina Millson, Uma H. Athale

Blood (2022) 140 (Supplement 1): 6044–6045.

https://doi.org/10.1182/blood-2022-158844

Published: 2022

Journal Articles

Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium

Blood (2021) 138 (Supplement 1): 3396.

https://doi.org/10.1182/blood-2021-151313

Published: 2021

Journal Articles

Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data

Petros Pechlivanoglou, Linda Luu, Qing Li, Paul J. Gibson, Uma H. Athale, Mylene Bassal, Vicky R. Breakey, Serina Patel, Jason Pole, Rinku Sutradhar, Laura Wheaton, Nicole Mittmann, Sumit Gupta

Blood (2021) 138 (Supplement 1): 565.

https://doi.org/10.1182/blood-2021-154193

Published: 2021

Journal Articles

Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study

Vicky R. Breakey, Paul Nathan, Serina Patel, Laura Wheaton, Qing Li, Rinku Sutradhar, Mylene Bassal, Paul J. Gibson, Jason Pole, Uma H. Athale, Sumit Gupta

Blood (2021) 138 (Supplement 1): 839.

https://doi.org/10.1182/blood-2021-147326

Published: 2021

Journal Articles

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Uma H. Athale, MD, M.Sc., Traci M. Blonquist, MS, Kristen E. Stevenson, MS, Menachem Spira, Peter D. Cole, MD, Barbara L Asselin, MD, Luis A. Clavell, MD, Kara M. Kelly, MD, Caroline Laverdière, MDFRCPC, Jean-Marie Leclerc, MD, Bruno Michon, MD, Marshall A. Schorin, MD, Maria Luisa Sulis, MD, Jennifer J.G. Welch, MD, Marian H. Harris, MD PhD, Donna S. Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2017) 130 (Supplement 1): 1278.

https://doi.org/10.1182/blood.V130.Suppl_1.1278.1278

Published: 2017

Journal Articles

Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001

Blood (2016) 128 (22): 175.

https://doi.org/10.1182/blood.V128.22.175.175

Published: 2016

Journal Articles

Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): a Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium

Blood (2016) 128 (22): 1729.

https://doi.org/10.1182/blood.V128.22.1729.1729

Published: 2016

Journal Articles

Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco

Romaric Massi, Resident physician, Mouna Lamchahab, MD, Hanaa Bencharef, Resident Physician, Bienvenu Houssou, resident, Nisrine Khoubila, MD, Siham Cherkoui, MD, Meryem Qachouh, MD, Mohamed Rachid, MD, Abdallah Madani, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2016) 128 (22): 5173.

https://doi.org/10.1182/blood.V128.22.5173.5173

Published: 2016

Journal Articles

Outcome of Acute Myeloid Leukemia in Children and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco

Bienvenu Houssou, resident, Mouna Lamchahab, MD, Romaric Massi, Resident physician, Nisrine Khoubila, MD, Siham Cherkaoui, MD, Meryem Qachouh, MD, Mohamed Rachid, MD, Abdallah Madani, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2016) 128 (22): 5176.

https://doi.org/10.1182/blood.V128.22.5176.5176

Published: 2016

Journal Articles

Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca

Romaric Massi, Resident physician, Mouna Lamchahab, MD, Bienvenu Houssou, resident, Nisrine Khoubila, MD, Siham Cherkoui, MD, Meryem Qachouh, MD, Mohamed Rachid, MD, Abdallah Madani, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2016) 128 (22): 5177.

https://doi.org/10.1182/blood.V128.22.5177.5177

Published: 2016

Journal Articles

Anticoagulation Therapy for Thrombotic Events in Paediatric Cancer Patients with Low Platelet Counts

Abha Athale, MSc, B.ASc., Uma H. Athale, MD, M.Sc., Leonardo R. Brandão, MD MSc

Blood (2016) 128 (22): 2625.

https://doi.org/10.1182/blood.V128.22.2625.2625

Published: 2016

Journal Articles

Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocols 00-001 and 05-001

Uma H. Athale, MD, M.Sc., Maneka Puligandla, MS, Kristen E. Stevenson, MS, Barbara L. Asselin, MD, Luis A. Clavell, MD, Peter D. Cole, MD, Kara M. Kelly, MD, Caroline Laverdiere, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD, Marshall A. Schorin, MD, Maria Luisa Sulis, MD, Jennifer J.G. Welch, MD, Marian H. Harris, MD PhD, Donna S. Neuberg, Sc.D., Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2016) 128 (22): 761.

https://doi.org/10.1182/blood.V128.22.761.761

Published: 2016

Journal Articles

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Justine Kahn, MD, Sergio Barrera, Randy Davila, Emily Roberts, ZheZhen Jin, PhD, Kristen Stevenson, MS, Traci M. Blonquist, MS, Donna S Neuberg, ScD, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Caroline Laverdiere, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Kara M. Kelly, MD

Blood (2015) 126 (23): 248.

https://doi.org/10.1182/blood.V126.23.248.248

Published: 2015

Journal Articles

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Maria Luisa Sulis, MD, Traci M. Blonquist, MS, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter D. Cole, MD, Kara M. Kelly, MD, Caroline Laverdiere, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Donna S Neuberg, ScD, Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 249.

https://doi.org/10.1182/blood.V126.23.249.249

Published: 2015

Journal Articles

Ikaros Gene Deletion Significantly Predicts Relapse in Pediatric B-ALL Patients with Low End-Induction Minimal Residual Disease

Marian H. Harris, MD PhD, Traci M. Blonquist, MS, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter D. Cole, MD, Kara M. Kelly, MD, Caroline Laverdiere, MD, Jean-Marie Leclerc, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Donna S. Neuberg, Sc.D., Stephen E. Sallan, MD, Lewis B. Silverman, MD

Blood (2015) 126 (23): 2613.

https://doi.org/10.1182/blood.V126.23.2613.2613

Published: 2015

Journal Articles

Favorable Risk Group Acute Myeloid Leukemia in Children and Young Adult Treated in Uniform Protocol in Casablanca, Morocco. a Preliminary Analysis

Igala Marielle, MD, Mouna Lamchaheb, MD, Nisrine Khoubila, MD, Siham Cherkaoui, MD, Bouchra Oukache, MD, Nazha Hda, MD, Uma H. Athale, MD, M.Sc., Asmaa AQ Quessar, MD

Blood (2015) 126 (23): 4891.

https://doi.org/10.1182/blood.V126.23.4891.4891

Published: 2015

Journal Articles

Effect of Asparaginase and Dexamethasone on FVIIa-at Complex and F1.2 in Children with Acute Lymphoblastic Leukemia: Evidence of Hypercoagulable State

Uma H. Athale, MD, M.Sc., Helen HM. Atkinson, M.Sc., Abha Athale, B.ASc., Trishana Nayiager, M.Sc., Anthony Chan, MBBS, FRCP(C), FRCPath

Blood (2015) 126 (23): 3552.

https://doi.org/10.1182/blood.V126.23.3552.3552

Published: 2015

Journal Articles

Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization

Khalid S Al-Habsi, MD FRCPath, Andrew W. Shih, MD BSc, Rebecca Barty, MLT, CTRC, Grace Wang, Allahna Elahie, MLT, Mona Azzam, MD, Reda Siddiqui, Michael Parvizian, Nancy M Heddle, MSc, Uma H. Athale, MD, M.Sc., Mindy Rona Goldman, MD FRCP(C), Madeleine M Verhovsek, BSc, MD FRCPC

Blood (2015) 126 (23): 3404.

https://doi.org/10.1182/blood.V126.23.3404.3404

Published: 2015

Journal Articles

Transition of Care Under One Roof at the Mcmaster Hemoglobinopathy Clinic

Madeleine M Verhovsek, BSc, MD FRCPC, Alannah Delahunty-Pike, BSc, MSc, Uma H. Athale, MD, M.Sc.

Blood (2014) 124 (21): 4851.

https://doi.org/10.1182/blood.V124.21.4851.4851

Published: 2014

NARROW

Impact of Thrombotic Events Occurring during Active Treatment of Leukemia on the Overall Survival and Event-Free Survival: A Systematic Review

Universal Premedication for Pegylated (PEG)-Asparaginase Treatment in Children with Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma (LLy) Has No Impact on Frequency of Hypersensitivity Reactions

Impact of Age, Body Surface Area, and Body Mass Index on Pegaspargase Toxicity and Pharmacokinetics: A Report from the DFCI ALL Consortium

Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data

Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study

Age and ABO Blood Group Are Significant Predictors of Thrombosis in Children with Acute Lymphoblastic Leukemia (ALL): Results from Dana-Farber Cancer Institute (DFCI) ALL Consortium Trial 05-001

Randomized Study of Pegasparagase (SS-PEG) and Calaspargase Pegol (SC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001

Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): a Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium

Outcome of acute Myeloid Leukemia in Adults Patients Treated According to Morocco National AML-MA-2011 Protocol in Casablanca, Morocco

Outcome of Acute Myeloid Leukemia in Children and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco

Evaluation of Mortality during Treatement of Acute Myeloid Leukemia in Patients According to Morocco National AML-MA-2011 Protocol in Casablanca

Anticoagulation Therapy for Thrombotic Events in Paediatric Cancer Patients with Low Platelet Counts

Excellent Outcome of Children with Down Syndrome (DS) and Acute Lymphoblastic Leukemia (ALL) Treated on Dana-Farber Cancer Institute (DFCI) ALL Consortium Protocols 00-001 and 05-001

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Effectiveness of Antibacterial Prophylaxis during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia

Ikaros Gene Deletion Significantly Predicts Relapse in Pediatric B-ALL Patients with Low End-Induction Minimal Residual Disease

Favorable Risk Group Acute Myeloid Leukemia in Children and Young Adult Treated in Uniform Protocol in Casablanca, Morocco. a Preliminary Analysis

Effect of Asparaginase and Dexamethasone on FVIIa-at Complex and F1.2 in Children with Acute Lymphoblastic Leukemia: Evidence of Hypercoagulable State

Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization

Transition of Care Under One Roof at the Mcmaster Hemoglobinopathy Clinic

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only